Convergent Dental, Inc.

Convergent Dental, Inc. develops innovative dental technology solutions, notably the Solea® laser system, which enhances dental procedures by offering anesthesia-free, blood-free, and suture-free treatments, improving both efficiency and patient comfort. Convergent Dental, Inc. is dedicated to transforming dental practices through advanced technology, headquartered in Needham, US.

Founded in 2011, the company has successfully completed 12 deals, with its most recent funding round on April 24, 2023, raising USD 20. 000 mn in VENTURE DEBT from Trinity Capital Investment. The company has raised a total of USD 10. 140 mn.

The CEO is Mike Cataldo and Rob Gershon, contributing to the leadership of the firm. Convergent Dental, Inc. specializes in innovative dental technology with its flagship product, Solea®, a CO₂ laser cleared by the FDA for all-tissue indications. Solea® delivers an anesthesia-free, blood-free, and suture-free experience, significantly improving the efficiency and effectiveness of dental procedures.

The technology operates at a unique 9. 3-micron wavelength, which optimally absorbs hydroxyapatite, allowing dentists to vaporize enamel rather than chipping it away. This effectively addresses a range of treatments, including restorative, soft tissue, and osseous procedures. The primary customer base includes dental practitioners aiming to enhance patient experience and operational efficiency, with marketing and sales primarily focused in North America and select international markets, aiming to transform dental practices globally.

Convergent Dental generates revenue through direct sales of its Solea® All-Tissue Laser and related services to dental practices. The company operates a B2B model, selling directly to dentists and dental clinics seeking to integrate advanced technology into their practices. While specific pricing details are not disclosed, the transaction structure typically involves capital purchases of laser systems along with potential service agreements for maintenance and training. The introduction of additional features like Solea® Perioguide™, an application for laser periodontal therapy, further diversifies revenue streams by encouraging existing clients to adopt supplementary services and products.

The business strategy focuses on fostering long-term relationships with dental professionals, ensuring ongoing support and improved clinical outcomes for their practices. In April 2023, Convergent Dental, Inc. raised USD 20. 000 mn in VENTURE DEBT funding, which will be utilized for growth expansion.

The company is actively designing upcoming products, including enhancements to the Solea® system, with plans to expand its market presence into new geographic regions. Specific targeted markets for expansion include both North America and select international territories, aimed at broadening the reach of its innovative dental solutions.